Search results for " differentiation markers"

showing 5 items of 5 documents

Proteomic differentiation pattern in the U937 cell line

2011

The U937 cell line, originally established from a histiocytic lymphoma, has been widely used as a powerful in vitro model for haematological studies. These cells retain the immature cell phenotype and can be induced to differentiate by several factors, among which 12-O-tetradecanoyl-13-phorbol acetate (TPA). Fully differentiated cells acquire the adherent phenotype and exhibit various properties typical of macrophages. However, in spite of a great deal of research devoted to the U937 cellular model, the molecular basis of biological processes involved in the monocyte/macrophage differentiation remains unclear. The present study has been undertaken to contribute to this knowledge, in order t…

ProteomicsCancer ResearchCellular differentiationBlotting WesternBiologyProteomicsMonocytesImmunophenotypingProto-Oncogene Proteins c-mycImmunophenotypingmedicineHumansElectrophoresis Gel Two-DimensionalU937 cellReverse Transcriptase Polymerase Chain ReactionCell growthMonocyteCell DifferentiationU937 CellsHematologyPhenotypePROTEOMICS DIFFERENTIATION MARKERS U937 CELL LINECell biologymedicine.anatomical_structureOncologySpectrometry Mass Matrix-Assisted Laser Desorption-IonizationCarcinogensTetradecanoylphorbol AcetateCellular modelLeukemia Research
researchProduct

Perinatal and Wharton's jelly-derived mesenchymal stem cells in cartilage regenerative medicine and tissue engineering strategies

2011

Stem cells can be found in embryonic and extraembryonic tissues as well as in adult organs. In particular, research in the last few years has delineated the key features of perinatal stem cells derived from fetus-associated tissues. These cells show multiple differentiation potential, can be easily expanded ex vivo, and raise no ethical concerns as regards their use. Several reports indicate that cells isolated from Wharton's jelly (WJ), the main component of umbilical cord extracellular matrix, are multipotent stem cells that express markers shared by other mesenchymal stem cells (MSC) and give rise to different mature cell types belonging to all three germ layers. Moreover, WJ-MSC display…

Settore BIO/16 - Anatomia UmanaMesenchymal stem cellClinical uses of mesenchymal stem cellsBiologyRegenerative medicineCell biologyDevelopmental NeuroscienceMultipotent Stem CellWharton's jellyImmunologyArticular cartilage Chondrocytes Differentiation markers Extracellular matrix Mesenchymal stem cells scaffolds Tissue engineering Umbilical cord Wharton’s jellyStem cellDevelopmental BiologyStem cell transplantation for articular cartilage repairAdult stem cell
researchProduct

Cell differentiation markers in human umbilical cord; an immunohistochemical study

2011

The full-term human umbilical cord is made of three blood vessels (two arteries and a vein) surrounded by the Wharton’s jelly, a soft connective tissue made of few mesenchymal stromal cells and an abundant extracellular matrix. Both endothelial and Wharton’s jelly cells are versatile in their differentiation potential; they have shown to be able to differentiate into several cell lineages. Since the differentiation potential of these cells is very wide, we thought it could be interesting to investigate the expression of several cell differentiation markers in the different regions of human umbilical cord. Immunohistochemistry showed the expression of E-cadherin and cytokeratins in the amnio…

human umbilical cord differentiation markers
researchProduct

Proteomic discovery of new differentiation markers in the U937 cell line

2009

Settore BIO/18 - Geneticaproteomics U937 differentiation markersSettore BIO/06 - Anatomia Comparata E Citologia
researchProduct

Wharton’s Jelly Mesenchymal Stem Cells as Candidates for Beta Cells Regeneration: Extending the Differentiative and Immunomodulatory Benefits of Adul…

2010

Mesenchymal stem cells (MSC) are uniquely capable of crossing germinative layers borders (i.e. are able to differentiate towards ectoderm-, mesoderm- and endoderm-derived cytotypes) and are viewed as promising cells for regenerative medicine approaches in several diseases. Type I diabetes therapy should potentially benefit from such differentiated cells: the search for alternatives to organ/islet transplantation strategies via stem cells differentiation is an ongoing task, significant goals having been achieved in most experimental settings (e.g. insulin production and euglycaemia restoration), though caution is still needed to ensure safe and durable effects in vivo. MSC are obtainable in …

Graft RejectionCancer ResearchCellular differentiationCell Culture TechniquesClinical uses of mesenchymal stem cellsBiologyMesenchymal Stem Cell TransplantationRegenerative medicineUmbilical CordImmunomodulationMesenchymal stem cells Umbilical cord Wharton’s jelly Type 1 diabetes Beta cells Differentiation markers Pancreas development Inflammation Immune modulation HypoimmunogenicityInsulin-Secreting CellsWharton's jellyAnimalsHumansRegenerationEmbryonic Stem CellsSettore BIO/16 - Anatomia UmanaRegeneration (biology)Mesenchymal stem cellCell DifferentiationMesenchymal Stem CellsCell BiologyAntigens DifferentiationTransplantationAdult Stem CellsDiabetes Mellitus Type 1Adipose TissueImmunologyCancer researchCord Blood Stem Cell TransplantationStem cellStem Cell Reviews and Reports
researchProduct